HK126095A - Hepatitis a virus vaccines - Google Patents
Hepatitis a virus vaccinesInfo
- Publication number
- HK126095A HK126095A HK126095A HK126095A HK126095A HK 126095 A HK126095 A HK 126095A HK 126095 A HK126095 A HK 126095A HK 126095 A HK126095 A HK 126095A HK 126095 A HK126095 A HK 126095A
- Authority
- HK
- Hong Kong
- Prior art keywords
- hav
- preparation
- hepatitis
- virus
- genome
- Prior art date
Links
- 241000709721 Hepatovirus A Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 title abstract 4
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 241000991587 Enterovirus C Species 0.000 abstract 1
- 241000709664 Picornaviridae Species 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 108010026228 mRNA guanylyltransferase Proteins 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 210000002845 virion Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
- C12N2770/32434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71932985A | 1985-04-03 | 1985-04-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK126095A true HK126095A (en) | 1995-08-11 |
Family
ID=24889649
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK126095A HK126095A (en) | 1985-04-03 | 1995-08-03 | Hepatitis a virus vaccines |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0199480B1 (fr) |
AT (1) | ATE77832T1 (fr) |
CA (1) | CA1324094C (fr) |
DE (1) | DE3685837T2 (fr) |
HK (1) | HK126095A (fr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4596674A (en) * | 1984-09-11 | 1986-06-24 | Merck & Co., Inc. | Immunogenic HAV peptides |
SU1469856A1 (ru) * | 1986-07-31 | 1990-09-30 | Институт биоорганической химии им.М.М.Шемякина | Способ конструировани рекомбинантной плазмидной ДНК, кодирующей синтез полипептидных субстанций против гепатита А |
WO1988002026A1 (fr) * | 1986-09-08 | 1988-03-24 | Applied Biotechnology, Inc. | Vaccins de capsides viraux vides |
EP0299242A3 (fr) * | 1987-06-22 | 1989-01-25 | Medico Labs Ag | Particules immunogènes peptiques virales hétérologues |
US5294548A (en) * | 1990-04-02 | 1994-03-15 | American Biogenetic Sciences, Inc | Recombianant Hepatitis a virus |
EP0491077A1 (fr) * | 1990-12-19 | 1992-06-24 | Medeva Holdings B.V. | Composition utilisée comme agent thérapeutique contre des maladies hépatiques chroniques |
WO1992015711A1 (fr) * | 1991-03-06 | 1992-09-17 | Regents Of The University Of Minnesota | Procede de determination de hla base sur des sequences d'adn |
HRP950097A2 (en) | 1994-03-08 | 1997-06-30 | Merck & Co Inc | Hepatitis a virus culture process |
JP2002506419A (ja) * | 1996-04-19 | 2002-02-26 | アメリカ合衆国 | A型肝炎ウイルスポリタンパク質の抗原反応性領域 |
EP1771585B1 (fr) | 2004-07-13 | 2012-09-26 | Gen-Probe Incorporated | Compositions et procedes de detection d'un acide nucleique du virus de l'hepatite a |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4031203A (en) * | 1974-12-09 | 1977-06-21 | Merck & Co., Inc. | Hepatitis A antigen |
US4164566A (en) * | 1978-08-17 | 1979-08-14 | Merck & Co., Inc. | Hepatitis a virus cell culture in vitro |
DE3112338C2 (de) * | 1981-03-28 | 1995-02-23 | Klaus Von Der Helm | Verwendung von Hybridisierungssonden zum Nachweis von HAV |
DE3484244D1 (de) * | 1983-09-30 | 1991-04-11 | Massachusetts Inst Technology | Herstellung von cdna die hepatitis a virale sequenzen darstellen. |
DE3582812D1 (de) * | 1984-03-02 | 1991-06-20 | Merck & Co Inc | Dns-fragmente welche fuer peptide kodieren, die faehig sind in vivo die synthese von antihepatitis-a-virus-antikoerpern zu induzieren. |
US4596674A (en) * | 1984-09-11 | 1986-06-24 | Merck & Co., Inc. | Immunogenic HAV peptides |
-
1986
- 1986-04-02 CA CA000505692A patent/CA1324094C/fr not_active Expired - Fee Related
- 1986-04-03 AT AT86302465T patent/ATE77832T1/de not_active IP Right Cessation
- 1986-04-03 EP EP86302465A patent/EP0199480B1/fr not_active Expired - Lifetime
- 1986-04-03 DE DE8686302465T patent/DE3685837T2/de not_active Revoked
-
1995
- 1995-08-03 HK HK126095A patent/HK126095A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP0199480A2 (fr) | 1986-10-29 |
DE3685837D1 (de) | 1992-08-06 |
ATE77832T1 (de) | 1992-07-15 |
EP0199480B1 (fr) | 1992-07-01 |
EP0199480A3 (en) | 1987-12-09 |
CA1324094C (fr) | 1993-11-09 |
DE3685837T2 (de) | 1992-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Lee et al. | Optimal induction of hepatitis C virus envelope-specific immunity by bicistronic plasmid DNA inoculation with the granulocyte-macrophage colony-stimulating factor gene | |
JP2001527029A5 (fr) | ||
DK0725824T3 (da) | Immunodominante humane T-celleepitoper af hepatitis C virus | |
MY103182A (en) | Vaccines against acquired immune deficiency syndrome. | |
KR950702839A (ko) | 레트로, 인버소-, 및 레트로- 인버소 합성 펩티드 유사체(retro-, inverso-, and retro-inverso synthetic peptide analogues) | |
HK126095A (en) | Hepatitis a virus vaccines | |
Murray et al. | Protective immunisation against hepatitis B with an internal antigen of the virus | |
CA2389206A1 (fr) | Activation de lymphocytes t specifiques au virus de l'hepatite c | |
DE3268361D1 (en) | New vaccine and therapy against non-a non-b viral hepatitis, and their preparation process | |
NO167359C (no) | Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus. | |
CA2417719A1 (fr) | Particules de type virus ameliorees fondees sur une petite proteine d'enveloppe provenant de l'hepatite b (aghbs) | |
EP0257721B1 (fr) | Vaccin | |
NZ295056A (en) | Hepatitis virus e strain, recombinant proteins thereof, use in diagnostic methods and vaccines | |
NZ220500A (en) | Recombinant felv polypeptide; vaccine and expression vectors | |
Deinhardt et al. | Vaccines against hepatitis | |
Gerin et al. | Recombinant DNA and synthetic peptide approaches to HBV vaccine development: Immunogenicity and protective efficacy in chimpanzees. | |
Zuckerman | Novel hepatitis B vaccines | |
WO1999066033A1 (fr) | Expression ciblee sur la surface de la proteine d'enveloppe du virus c de l'hepatite modifiee | |
AU2006235980B9 (en) | HIV peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by HIV | |
DK645687A (da) | Fremgangsmaade til fremstilling af en vaccine mod hepatitis b og den opnaaede vaccine | |
AU2001276182B2 (en) | Improved virus like particles based on small envelope protein from hepatitis B (HBsAg-S) | |
Leclerc | Vaccination against HIV and SIV | |
Ivanov et al. | Towards synthetic antiviral vaccines | |
PRINCE | Hepatitis B Vaccine and the Developing World | |
Kennedy et al. | HEPATITIS B SURFACE ANTIGEN POLYPEPTIDE AND SYNTHETIC PEPTIDE VACCINES |